Opinion|Videos|November 12, 2026
Lifestyle changes and the management of hidradenitis suppurativa
Author(s)Martina Porter, MD
Telling patients that being overweight or smoking caused their HS puts the responsibility back on them and has created barriers to seeking and staying in care, Porter said.
Advertisement
Episodes in this series
Telling patients that being overweight or smoking caused their HS puts the responsibility back on them and has created barriers to seeking and staying in care, Porter said. Weight loss can relieve symptoms in very mild disease, but no amount of weight loss or lifestyle modification will take away the inflammation of moderate or more severe hidradenitis suppurativa, she notes, although patients can benefit from the glucagon-like peptide 1 drugs. Porter observed that, as in polyendocrine metabolic ovarian syndrome, obesity may be part of the hidradenitis suppurativa rather than a cause of it. Telling patients with severe cases who can barely lift their arms, sit or walk to exercise to lose weight is not helpful, she said.
Advertisement
Related to this article
Adding Sunharbo (asundexian), a first-in-class Factor XI inhibitor, to single or dual antiplatelet therapy reduces ischemic stroke risk without increasing the risk of major bleeding.
In this discussion, University College London colleagues Joshua Stott, Ph.D., professor of aging and clinical psychology and research assistant Lucy Corrigan, who led the work while at the University of Liverpool, talk about their recent meta-analysis linking ADHD to a higher risk of death from all causes, including suicide, injury and natural causes.
The American Academy of Sleep Medicine’s first update since 2007 favors generic drugs, caffeine, light and naps, and advises against benzodiazepines.
People with advanced Parkinson’s disease who also have a sleep disorder cost about $50,000 a year to treat, $13,000 more than similar patients without one, according to an AbbVie-funded claims analysis.
Geisinger Health Plan President Jeremy Gaskill says the possibility that a growing number of patients won't have health insurance could put tremendous financial pressure on the plan's providers.
γδ T cells infiltrate small cell lung cancer tumors and can kill them without the MHC-I machinery these tumors typically switch off, and patients with more of them trended toward longer survival on anti-PD-L1 immunotherapy.
Upstream payment accuracy should reduce avoidable noise before it reaches those downstream functions.
The results come several months after the FDA approved Lisraya for dermatomyositis.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
As psychedelic drugs near FDA decisions, people with HIV remain absent from trials, commentary says
2
A new strategy for secondary stroke prevention gets boost from FDA approval
3
Payment integrity is necessary. But timing determines its impact
4
Quick Q&A: Jeremy Gaskill on the uninsured and pressure on providers
5